Status:

UNKNOWN

Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology

Lead Sponsor:

LumaMed

Collaborating Sponsors:

University of Wisconsin, Madison

Conditions:

Breast Cancer

Eligibility:

FEMALE

18-70 years

Phase:

EARLY_PHASE1

Brief Summary

This study will evaluate LumaScan, an innovative polarization microscope for real time, intraoperative imaging and evaluation of the surface of excised tissue excised during Breast Conservation Surger...

Detailed Description

LumaScan is an innovative polarization microscope that uses Polarization Subtraction Imaging (PSI) technology to provide real time, intra operative, digital images of the surface of tissue removed dur...

Eligibility Criteria

Inclusion

  • Women referred for breast conservation surgery following a diagnosis of invasive or in situ carcinoma of the breast by histopathology or women referred for lumpectomy due to a benign (fibroadenoma or papilloma) or high risk breast lesion(Atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma in-situ, atypical papilloma).
  • 18 years of age or older.
  • Able to read or understand and give informed consent.

Exclusion

  • Patients undergoing neo-adjuvant systemic therapy.
  • Previous breast cancer and /or radiation in the operated breast.
  • Implants in the operated breast.
  • Pregnant or Lactating.
  • History of photosensitizing disease (porphyria, lupus etc.) or of allergy to methylene blue dye.
  • Recent use of photosensitizing agents such as fluoroquinolones and retinoids or patients undergoing phototherapy.
  • Participation in any other intraoperative margin assessment protocol that would affect data acquisition.
  • Subareolar location (cancer is directly and completely under the nipple/areolar complex) of breast abnormality.
  • Patients for whom English is not their native language

Key Trial Info

Start Date :

January 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2015

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT02207179

Start Date

January 1 2014

End Date

November 1 2015

Last Update

March 31 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Wisconsin

Madison, Wisconsin, United States, 53792

Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology | DecenTrialz